Published in Arthritis Rheum on July 01, 1999
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest (2003) 2.39
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Seronegative antiphospholipid syndrome. Ann Rheum Dis (2003) 1.90
Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus. J Rheumatol (2013) 1.75
Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study. J Pediatr (2009) 1.72
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum (2012) 1.66
Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther (2009) 1.61
Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther (2005) 1.57
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol (2012) 1.56
Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatol Int (2010) 1.51
Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis (2003) 1.46
Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis (2005) 1.44
β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood (2015) 1.42
How to treat women with antiphospholipid antibodies in pregnancy? Ann Rheum Dis (2001) 1.41
Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. Lupus Sci Med (2016) 1.41
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis (2003) 1.38
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood (2006) 1.34
The lung in the antiphospholipid syndrome. Ann Rheum Dis (2002) 1.33
Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy. Ann Rheum Dis (2003) 1.22
Renal involvement in autoimmune connective tissue diseases. BMC Med (2013) 1.21
Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther (2009) 1.20
Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature. J Cardiothorac Surg (2010) 1.18
The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis (2005) 1.17
Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol (2003) 1.16
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis (2004) 1.15
Real world experience with antiphospholipid antibody tests: how stable are results over time? Ann Rheum Dis (2005) 1.15
The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther (2013) 1.13
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol (2008) 1.13
Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis. Ann Rheum Dis (2002) 1.13
Retracted Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood (2005) 1.12
Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum (2007) 1.12
Cognitive impairment in antiphospholipid syndrome: evidence from animal models. Clin Rheumatol (2012) 1.08
Antiphospholipid syndrome: an overview. CMAJ (2003) 1.05
Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients. Clin J Am Soc Nephrol (2010) 1.05
Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis (2003) 1.04
Antiphospholipid Syndrome during pregnancy: the state of the art. J Prenat Med (2011) 1.02
D-dimer level and the risk for thrombosis in systemic lupus erythematosus. Clin J Am Soc Nephrol (2008) 1.00
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies. Thromb Haemost (2003) 0.99
Epidemiology and etiology of young stroke. Stroke Res Treat (2011) 0.98
Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int (2011) 0.98
Clinical outcomes of childhood lupus nephritis: a single center's experience. Pediatr Nephrol (2006) 0.98
Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis (2001) 0.96
High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis (2004) 0.96
Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol (2007) 0.96
European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis (2012) 0.95
Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum (2007) 0.95
Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis (2005) 0.94
Antiphospholipid antibodies: paradigm in transition. J Neuroinflammation (2009) 0.94
Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment. Ther Clin Risk Manag (2008) 0.94
Rare association of antiphospholipid syndrome and Takayasu arteritis. Clin Rheumatol (2006) 0.94
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. Ther Adv Musculoskelet Dis (2013) 0.94
Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol (2007) 0.93
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis (2003) 0.93
Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome. Arthritis Rheum (2005) 0.92
The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis (2005) 0.92
Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis (2007) 0.91
Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis (2006) 0.91
Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome. Clin Rheumatol (2012) 0.91
A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli. BMC Biotechnol (2006) 0.90
Antiphospholipid antibodies in HIV-positive patients. Clin Rheumatol (2007) 0.90
High prevalence of co-factor independent anticardiolipin antibodies in malaria exposed individuals. Clin Exp Immunol (2002) 0.90
Recurrent pregnancy loss and thrombophilia. J Clin Med Res (2010) 0.90
Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am J Hematol (2012) 0.90
Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon. Clin Rheumatol (2010) 0.90
Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies. Lupus Sci Med (2014) 0.89
Development of additional autoimmune diseases in a multiethnic cohort of patients with systemic lupus erythematosus with reference to damage and mortality. Ann Rheum Dis (2007) 0.89
Thrombotic complications in childhood-onset idiopathic membranous nephropathy. Pediatr Nephrol (2003) 0.89
Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol (2000) 0.88
Primary antiphospholipid syndrome as a new cause of autoimmune pancreatitis. Gut (2004) 0.88
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. Clin Exp Immunol (2005) 0.88
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis (2004) 0.88
Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheum Dis (2006) 0.88
The mosaic of "seronegative" antiphospholipid syndrome. J Immunol Res (2014) 0.87
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol (2003) 0.87
Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Clin Exp Immunol (2000) 0.87
Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut (2004) 0.86
Serological and clinical comparison of children and adults with anti-endomysial antibodies. J Clin Immunol (2007) 0.86
Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. Rheumatol Int (2009) 0.86
Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol (2006) 0.86
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis. Thromb Haemost (2004) 0.86
Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation. Trans Am Clin Climatol Assoc (2007) 0.86
Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients. Rheumatol Int (2012) 0.86
IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events. Clin Rheumatol (2005) 0.85
My approach to internal quality control in a clinical immunology laboratory. J Clin Pathol (2006) 0.85
Anti-beta2GPI-antibody-induced endothelial cell gene expression profiling reveals induction of novel pro-inflammatory genes potentially involved in primary antiphospholipid syndrome. Ann Rheum Dis (2007) 0.85
Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss. Clin Exp Immunol (2008) 0.85
Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case. Clin Rheumatol (2005) 0.85
Mania: psychiatric manifestations of the antiphospholipid syndrome. Psychosomatics (2008) 0.85
Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies. Clin Rheumatol (2006) 0.85
Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis. Arthritis Res Ther (2006) 0.84
Prothrombotic States that Predispose to Stroke. Curr Treat Options Neurol (2002) 0.84
Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis (2005) 0.84
Antibodies against the activated coagulation factor X (FXa) in the antiphospholipid syndrome that interfere with the FXa inactivation by antithrombin. J Immunol (2006) 0.84
The role of hypercoagulability in the development of osteonecrosis of the femoral head. Orthop Rev (Pavia) (2012) 0.84
Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature. Clin Rheumatol (2013) 0.84
Possible novel biomarkers of organ involvement in systemic lupus erythematosus. Clin Rheumatol (2014) 0.83
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) (1984) 6.40
Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet (1971) 6.22
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Systemic lupus erythematosus. Lancet (2001) 4.18
Cultivation of the bacillus of Whipple's disease. N Engl J Med (2000) 3.97
Anti-DNA activity in systemic lupus erythematosus. A diagnostic and therapeutic guide. Ann Rheum Dis (1971) 3.76
Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis (1987) 3.62
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 3.53
Anti-phospholipid antibodies. Clin Rheum Dis (1985) 3.43
Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1983) 3.39
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol (1985) 3.38
The anticardiolipin syndrome. J Rheumatol (1986) 3.36
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Editorial: The First Specialist Qualification Examination of the Japanese Society of Intravascular Neurosurgery (JSIN). Interv Neuroradiol (2004) 3.03
Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol (1987) 3.02
Diagnosis and long-term follow-up of the Brugada syndrome in patients with idiopathic ventricular fibrillation. Eur Heart J (2001) 3.02
Systemic capillary leak syndrome: report on 13 patients with special focus on course and treatment. Am J Med (1997) 3.01
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost (1995) 2.95
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet (1990) 2.87
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol (1996) 2.83
Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost (2004) 2.79
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med (1985) 2.62
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol (1985) 2.51
Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol (1984) 2.43
Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 2.35
Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med (1986) 2.35
The key role of nucleosomes in lupus. Arthritis Rheum (1999) 2.26
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
Crossed aphasia elicited by direct cortical stimulation. Neurology (2006) 2.15
Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis (1978) 2.12
Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation (2001) 2.11
Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet (1982) 2.10
Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med (1996) 2.10
Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09
Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol (1985) 2.07
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut (2000) 2.06
Obstetric complications associated with the lupus anticoagulant. N Engl J Med (1985) 2.05
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2010) 2.05
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene (1995) 2.05
Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis (2010) 2.04
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Sjögren's syndrome and autoimmunity in a geriatric population. Age Ageing (1972) 2.01
Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther (2015) 2.01
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis (2007) 2.01
Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med (1975) 2.00
Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore) (1976) 1.98
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases. Lupus (2009) 1.97
Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of ARA criteria. J Rheumatol (1992) 1.94
Specificity of mouse hybridoma antibodies to DNA. Immunol Lett (1982) 1.93
Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol (1985) 1.92
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 1.90
Seronegative antiphospholipid syndrome. Ann Rheum Dis (2003) 1.90
Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg (1994) 1.87
Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice. Diabetes (1987) 1.86
Arterial lesions in Behçet's disease. A study in 25 patients. J Rheumatol (1995) 1.85
Acute synovial rupture of the knee--a differential diagnosis from deep vein thrombosis. Proc R Soc Med (1970) 1.85
Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis. Arthritis Rheum (1973) 1.83
Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med (1977) 1.83
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation (1999) 1.82
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80
Syndrome of the black swan. Br J Rheumatol (1987) 1.80